Project Twenty21
London, United KingdomFounded 2020
About Project Twenty21
Project Twenty21 is Europe's largest medical cannabis registry, run by Drug Science, collecting real-world patient data to build the evidence base for prescribing.
Key Facts
- 1Europe's largest observational study of medical cannabis patients
- 2Aims to create the evidence base needed for NHS prescribing of cannabis-based medicines
Frequently Asked Questions
What is Project Twenty21?
Project Twenty21 is a national medical cannabis patient registry run by Drug Science that collects real-world outcome data to build evidence for wider access.
Can patients join Project Twenty21?
Patients prescribed medical cannabis through participating clinics can enrol in the registry, often benefiting from subsidised medication costs.
More Cannabis Companies in London
Cannabis Laws
Products
- Patient registry platform
- Real-world evidence data
Specialties
Medical cannabis real-world evidence collectionPatient registry management
Company Details
- Location
- London, United Kingdom
- Founded
- 2020
- Publicly Traded
- No
Browse all Technology & Equipment
View more companies in this category
Related Companies
More in United Kingdom
Zerenia Clinics
London \u2014 Medical & Pharma
Lyphe Group
London \u2014 Medical & Pharma
IPS Pharma
Leatherhead \u2014 Producer & Grower
GW Pharmaceuticals (Jazz Pharmaceuticals)
Cambridge \u2014 Medical & Pharma